AVGR News and Press, Avinger Inc. From 06/05/23

REDWOOD CITY, CA / ACCESSWIRE / June 5, 2023 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced the successful completion of the f...

2023-05-10 20:38:09 ET Avinger, Inc. (AVGR) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Matt Kreps – Darrow Associates Investor Relations Jeff Soinski – Chief Executive Officer Nabeel Subainati – Principal Fi...

2023-05-10 16:27:02 ET Avinger press release ( NASDAQ: AVGR ): Q1 GAAP EPS of -$0.71 misses by $0.22 . Revenue of $1.89M (-0.5% Y/Y) misses by $0.11M . For further details see: Avinger GAAP EPS of -$0.71 misses by $0.22, revenue of $1.89M misses by $0.11M

REDWOOD CITY, CA / ACCESSWIRE / May 10, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the fir...

REDWOOD CITY, CA / ACCESSWIRE / May 2, 2023 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial ...

REDWOOD CITY, CA / ACCESSWIRE / April 28, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the presentation ...

2023-04-26 08:22:28 ET Avinger ( NASDAQ: AVGR ) has announced that the Co. has received 510(k) clearance from the U.S. FDA for Tigereye ® ST, its next-generation image-guided chronic total occlusion crossing system. Tigereye ST expands and advances Avinger's propr...

REDWOOD CITY, CA / ACCESSWIRE / April 26, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced the company has received 510(k) ...

2023-03-15 21:15:07 ET Avinger, Inc (AVGR) Q4 2022 Earnings Call March 15, 2023 4:30 PM Company Participants Matt Kreps - Darrow Associates Investor Relations Jeff Soinski - President, CEO & Director Nabeel Subainati - VP, Controller, Principal Financial Offi...

2023-03-15 16:16:58 ET Avinger press release ( NASDAQ: AVGR ): Q4 GAAP EPS of -$0.70. Revenue of $2M (-16.7% Y/Y). For further details see: Avinger GAAP EPS of -$0.70, revenue of $2M